[EN] NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS<br/>[FR] DÉRIVÉS DE NAPHTYRIDINE EN TANT QU'INHIBITEURS DE PRC2
申请人:MIRATI THERAPEUTICS INC
公开号:WO2020219448A1
公开(公告)日:2020-10-29
Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
Palladium-catalyzed cross-coupling of benzyltitanium(IV) reagents with aryl fluorides
作者:Yan Li
DOI:10.1007/s00706-021-02881-w
日期:2022.2
The first palladium-catalyzed cross-coupling between benzyltitanium(IV) reagents with aryl fluorides is reported. A variety of diarylmethanes can be prepared in good to excellent yields by the catalyst system of PdCl2(dppf)2 associated with 1-[2-(di-tert-butylphosphanyl)phenyl]-4-methoxypiperidine. This reaction offered a highly efficient approach to diarylmethanes that are commonly found in life-changing
[EN] SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS<br/>[FR] SYSTÈME DE FLUORATION DE COMPOSÉS ORGANIQUES
申请人:HARVARD COLLEGE
公开号:WO2009100014A1
公开(公告)日:2009-08-13
Described herein are fluorinated organic compounds and methods of making fluorinated organic compounds, for example, using palladium complexes. Also described herein are compositions and kits containing compounds and palladium complexes described herein.
Compounds of formula (I) and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and the use of such compounds and compositions for use in therapy.